Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy NexImmune (NEXI) stocks in Canada
Learn how to easily invest in NexImmune stocks.
NexImmune is a biotechnology business based in the US. NexImmune stocks (NEXI.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $14.31 – a decrease of 18.06% over the previous week. NexImmune employs 44 staff and has a market cap (total outstanding stock value) of $84.3 million.
How to buy shares in NexImmune
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – NEXI – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
NexImmune stock price (NASDAQ:NEXI)Use our graph to track the performance of NEXI stocks over time.
NexImmune shares at a glance
|Latest market close||$3.04|
|52-week range||$3.57 - $28.00|
|50-day moving average||$6.91|
|200-day moving average||$13.28|
|Wall St. target price||$30.33|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-3.01|
Compare online stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy NexImmune stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
NexImmune price performance over time
|1 week (2022-01-14)||-18.06%|
|1 month (2021-12-23)||-37.32%|
|3 months (2021-10-22)||-76.40%|
|6 months (2021-07-23)||-71.51%|
|1 year (2021-01-20)||N/A|
|2 years (2020-01-20)||N/A|
|3 years (2019-01-20)||N/A|
|5 years (2017-01-20)||N/A|
|Gross profit TTM||$0|
|Return on assets TTM||-50.32%|
|Return on equity TTM||-98.75%|
|Market capitalisation||$84.3 million|
TTM: trailing 12 months
NexImmune share dividends
We're not expecting NexImmune to pay a dividend over the next 12 months.
NexImmune, Inc. , a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation, a nanoparticle technology platform. The company's product candidates include NEXI-001, an allogeneic cell therapy, which is in Phase I/II clinical trials for the treatment of patients with acute myeloid leukemia; and NEXI-002, an autologous cell therapy, which is in Phase I/II clinical trials for the treatment of patients with relapsed and/or refractory in multiple myeloma. NexImmune, Inc. was incorporated in 2011 and is headquartered in Gaithersburg, Maryland. .
Stocks similar to NexImmune
NexImmune in the news
Stocks making the biggest moves midday: Netflix, Kohl's, Wynn Resorts, General Motors and more
RBC upgrades Comcast to outperform on subscriber growth
What to watch today: Wall Street to open lower after Nasdaq's worst week since March 2020
Frequently asked questions
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.
More guides on Finder
How to buy Haemonetics Corporation stock in Canada
Steps to owning and managing HAE stock, with 24-hour and historical pricing before you buy.
Go Auto Review
Use Go Auto to shop for new or used vehicles from multiple dealerships, with no hidden fees and access to bad credit financing.
How to buy Aritzia stock in Canada
Steps to owning and managing Aritzia (ATZ) stock, with 24-hour and historical pricing before you buy.
CI Direct Trading review
Get low fees and access many different types of accounts, platforms and investments with this reputable online broker.
Hifi Finance (MFT) price prediction
Read our expert analysis on Hifi Finance and how the token will perform in the future.
Kusama (KSM) price prediction
Read our expert analysis on Kusama and how the token will perform in the future.
How to buy The Sandbox (SAND) in Canada
This guide provides step-by-step instructions on how to buy The Sandbox, lists some exchanges where you can get it and provides daily price data on SAND.
COVID testing stocks
We’ve rounded up stats on some of the most popular COVID testing stocks, along with information on how they compare and how to invest.
Shiba Inu (SHIB) price, history and performance
This guide explores the different ways of buying Shiba Inu on a cryptocurrency exchange as well as where you should store your cryptocurrency.
Baby Doge Coin (BABYDOGE) price, chart, coin profile and news
This guide provides step-by-step instructions on how to buy Baby Doge Coin, lists some exchanges where you can get it and provides daily price data on BABYDOGE.